Does IRBESARTAN Cause Affect lability? 257 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 257 reports of Affect lability have been filed in association with IRBESARTAN (Irbesartan). This represents 2.5% of all adverse event reports for IRBESARTAN.
257
Reports of Affect lability with IRBESARTAN
2.5%
of all IRBESARTAN reports
0
Deaths
249
Hospitalizations
How Dangerous Is Affect lability From IRBESARTAN?
Of the 257 reports, 249 (96.9%) required hospitalization, and 231 (89.9%) were considered life-threatening.
Is Affect lability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 257 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Affect lability?
DULOXETINE (2,510)
METFORMIN (291)
AMLODIPINE (274)
METHOTREXATE (266)
ATORVASTATIN (259)
LEVOTHYROXINE (251)
SITAGLIPTIN (244)
ESOMEPRAZOLE (234)
ASPIRIN (224)
PREDNISONE (196)
Which IRBESARTAN Alternatives Have Lower Affect lability Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE